Clinical trials
Showing of 27 results

New Scientific Research Sheds Light on the Role of Vitamins K2 MK-7 and D3 in Alleviating Long COVID Symptoms
A groundbreaking clinical trial conducted by University Hospitals and published in the peer-reviewed journal Nutrients has revealed that a daily dose of vitamin D3 and vitamin K2 MK-7 could help improve symptoms of long COVID.

Researchers at University Hospitals, Case Western Reserve to begin clinical testing with new, less-invasive technology to screen for esophageal precancer
Study supported by $8 million National Institutes of Health grant.

Cholesterol Drug Repurposed as Investigational Therapy for HPV+ Cancers at University Hospitals Seidman Cancer Center in Nation’s First-Ever Clinical Trials
UH Seidman Cancer Center will soon begin to look into the use of fenofibrate as a potential treatment for HPV+ cancers.

University Hospitals Awarded $7 Million by PCORI to Study Endovascular Thrombectomy in Patients Presenting Beyond 24 Hours
Dr. Amrou Sarraj will lead the study, which aims to provide deterministic evidence of clinical benefit due to addition of endovascular thrombectomy to standard medical care in this population.

Phase 1 BAFF CAR T Clinical Trial for Patients with Relapsed and Refractory Multiple Myeloma Underway at UH Seidman Cancer Center
Study is being done through an agreement between UH and Luminary Therapeutics.

University Hospitals Rainbow Babies & Children’s Sickle Cell Disease Patient to Represent the Hospital in Washington, DC
During the 2024 Children’s Hospital Association Family Advocacy Day Canaan Evans and his mom, Arenda will discuss their experience of participating in a clinical trial and undergoing an investigational treatment he says changed his life.

Cleveland Innovation District Partners Exceeding Many Targets Set by State and JobsOhio
25 examples of progress showcase the impact of successful collaboration.

International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes
Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in The Lancet presented at International Stroke Conference.